SHELLI KESLER to Breast Neoplasms
This is a "connection" page, showing publications SHELLI KESLER has written about Breast Neoplasms.
Connection Strength
2.717
-
Subjective cancer-related cognitive impairments and salience network connectivity in breast cancer survivors. J Cancer Surviv. 2023 08; 17(4):967-973.
Score: 0.160
-
Sustained effects of mantra meditation compared to music listening on neurocognitive outcomes of breast cancer survivors: A brief report of a randomized control trial. J Psychosom Res. 2021 11; 150:110628.
Score: 0.147
-
Changes in Brain Functional and Effective Connectivity After Treatment for Breast Cancer and Implications for Intervention Targets. Brain Connect. 2022 05; 12(4):385-397.
Score: 0.147
-
The association of genetic polymorphisms with neuroconnectivity in breast cancer patients. Sci Rep. 2021 03 17; 11(1):6169.
Score: 0.142
-
A novel approach to management of sleep-associated problems in patients with breast cancer (MOSAIC) during chemotherapy : A pilot study. Sleep. 2020 10 13; 43(10).
Score: 0.138
-
A randomized control trial of meditation compared to music listening to improve cognitive function for breast cancer survivors: Feasibility and acceptability. Complement Ther Clin Pract. 2020 Nov; 41:101228.
Score: 0.137
-
Cortical Brain Age from Pre-treatment to Post-chemotherapy in Patients with Breast Cancer. Neurotox Res. 2020 Apr; 37(4):788-799.
Score: 0.131
-
Predicting Patient Reported Outcomes of Cognitive Function Using Connectome-Based Predictive Modeling in Breast Cancer. Brain Topogr. 2020 01; 33(1):135-142.
Score: 0.130
-
Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors. Biol Res Nurs. 2020 01; 22(1):126-138.
Score: 0.129
-
Relationships between self-reported sleep quality components and cognitive functioning in breast cancer survivors up to 10?years following chemotherapy. Psychooncology. 2018 08; 27(8):1937-1943.
Score: 0.117
-
Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10?years post chemotherapy using machine learning. J Neuroimmunol. 2018 07 15; 320:38-47.
Score: 0.116
-
Disrupted brain network functional dynamics and hyper-correlation of structural and functional connectome topology in patients with breast cancer prior to treatment. Brain Behav. 2017 03; 7(3):e00643.
Score: 0.107
-
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. JAMA Oncol. 2016 Feb; 2(2):185-92.
Score: 0.100
-
Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer. Neurobiol Aging. 2015 Aug; 36(8):2429-42.
Score: 0.094
-
Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy. Brain Imaging Behav. 2013 Dec; 7(4):501-10.
Score: 0.086
-
Multivariate pattern analysis of FMRI in breast cancer survivors and healthy women. J Int Neuropsychol Soc. 2014 Apr; 20(4):391-401.
Score: 0.085
-
Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proc Natl Acad Sci U S A. 2013 Jul 09; 110(28):11600-5.
Score: 0.083
-
Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer. 2013 Aug; 13(4):299-306.
Score: 0.082
-
Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors. Neurobiol Dis. 2012 Dec; 48(3):329-38.
Score: 0.078
-
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun. 2013 Mar; 30 Suppl:S109-16.
Score: 0.077
-
Altered small-world properties of gray matter networks in breast cancer. BMC Neurol. 2012 May 28; 12:28.
Score: 0.077
-
Prefrontal cortex and executive function impairments in primary breast cancer. Arch Neurol. 2011 Nov; 68(11):1447-53.
Score: 0.074
-
Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin Cancer Res. 2009 Nov 01; 15(21):6665-73.
Score: 0.064
-
Effects of meditation compared to music listening on biomarkers in breast cancer survivors with cognitive complaints: secondary outcomes of a pilot randomized control trial. Explore (NY). 2022 Nov-Dec; 18(6):657-662.
Score: 0.037
-
Headache outcomes of a sleep behavioral intervention in breast cancer survivors: Secondary analysis of a randomized clinical trial. Cancer. 2021 Dec 01; 127(23):4492-4503.
Score: 0.036
-
Secondary outcomes of a behavioral sleep intervention: A randomized clinical trial. Health Psychol. 2019 Mar; 38(3):196-205.
Score: 0.031
-
Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer. 2018 Apr; 26(4):1019-1028.
Score: 0.028
-
Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10?years after chemotherapy completion. J Cancer Surviv. 2018 04; 12(2):224-233.
Score: 0.028
-
Management of side effects during and post-treatment in breast cancer survivors. Breast J. 2018 03; 24(2):167-175.
Score: 0.028
-
Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014 Feb; 26(1):102-13.
Score: 0.022
-
Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin. 2015 Mar; 65(2):123-38.
Score: 0.006